Current Cancer Drug Targets, Volume 9 - Number 6

Molecular Features, Markers, Drug Targets, and Prospective Targeted Therapeutics in Cardiac Myxoma

, 9(6): 705 - 716

Debmalya Barh, Anil Kumar, Suvro Chatterjee and Triantafillos Liloglou

DOI: 10.2174/156800909789271549

Caspase-Independent Pathways of Programmed Cell Death: The Unraveling of New Targets of Cancer Therapy?

, 9(6): 717 - 728

C. Constantinou, K. A. Papas and A. I. Constantinou

DOI: 10.2174/156800909789271512

The PI3K/Akt/mTOR Pathway as Therapeutic Target in Neuroblastoma

, 9(6): 729 - 737

S. Fulda

DOI: 10.2174/156800909789271521

Sunitinib (SUTENT, SU11248) Suppresses Tumor Growth and Induces Apoptosis in Xenograft Models of Human Hepatocellular Carcinoma

, 9(6): 738 - 747

H. Huynh, V. C. Ngo, S. P. Choo, D. Poon, H. N. Koong, C. H. Thng, H. C. Toh, L. Zheng, L. C. Ong, Y. Jin, I. C. Song, A. P.C. Chang, H. S. Ong, A. Y.F. Chung, P. K.H. Chow and K. C. Soo

DOI: 10.2174/156800909789271530

Crosstalk Between Epidermal Growth Factor Receptor- and Insulin-Like Growth Factor-1 Receptor Signaling: Implications for Cancer Therapy

, 9(6): 748 - 760

J. van der Veeken, S. Oliveira, R. M. Schiffelers, G. Storm, P.M.P. van Bergen en Henegouwen and R. C. Roovers

DOI: 10.2174/156800909789271495

Heat Shock Protein 90 – a Potential Target in the Treatment of Human Acute Myelogenous Leukemia

, 9(6): 761 - 776

H. Reikvam, E. Ersvær and O. Bruserud

DOI: 10.2174/156800909789271486

Increased Tumor Oxygenation and Drug Uptake During Anti-Angiogenic Weekly Low Dose Cyclophosphamide Enhances the Anti-Tumor Effect of Weekly Tirapazamine (Supplementry Material)

, 9(6): 777 - 788

J. C. Doloff, N. Khan, J. Ma, E. Demidenko, H. M. Swartz and Y. Jounaidi

DOI: 10.2174/156800909789271503

Webmaster Contact:
Copyright © 2018 Bentham Science